<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">Metabolic disorders</z:e> encompass a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of conditions that commonly affect the heart and contribute adversely to cardiovascular outcomes </plain></SENT>
<SENT sid="1" pm="."><plain>As the heart is a metabolically active organ, inborn errors in metabolism (IEMs) often present with cardiac manifestations such as <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>, and valvular dysfunction </plain></SENT>
<SENT sid="2" pm="."><plain>More than 40Â IEMs are reported to cause <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, including fatty acid oxidation defects, <z:chebi fb="15" ids="28087">glycogen</z:chebi>, lysosomal and perioxisome <z:e sem="disease" ids="C0267971" disease_type="Disease or Syndrome" abbrv="">storage diseases</z:e>, <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:hpo ids='HP_0001638'>cardiomyopathies</z:hpo>, organic acidaemias, <z:e sem="disease" ids="C0002514" disease_type="Disease or Syndrome" abbrv="">aminoacidopathies</z:e> and <z:e sem="disease" ids="C0242354" disease_type="Disease or Syndrome" abbrv="">congenital disorders</z:e> of glycosylation </plain></SENT>
<SENT sid="3" pm="."><plain>Studies suggest that IEM account for only 5% of <z:hpo ids='HP_0001638'>cardiomyopathies</z:hpo>; however, their diagnosis is imperative to enable the effective institution of disease-specific management strategies </plain></SENT>
<SENT sid="4" pm="."><plain>This review describes the more common genetic defects that affect metabolic pathways and give rise to heart muscle disease </plain></SENT>
</text></document>